N-(4-aminobutyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid
Structure Info
- Chemspace ID
- CSSB00138413549 (In-Stock Building Blocks)
- CAS
- 1799711-25-3
- MFCD
- MFCD31560484
- IUPAC Name
- N-(4-aminobutyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid
- Mol formula
- C21H23F3N4O8
- Mol weight
- 516 Da
- Catalog Number(s)
- 1799711-25-3, 350940, 5977EG, A724272, A9984, AA01EO6T, ACIMBU406, AG-B27104, AG01EO9L, AP13120, AR01EOYL, AT18334, AT18334-0.1G, AT18334-0.25G, AX64049, BBLS00138413549, BD00822294, BF64049, BUP14248, CS-7755, CSC138413549, EC01EQFD, EN300-7485106, F987661, HY-103613, M28568, PC108516, PR1799711253, ST01EPQD, SY504220, T7759, TX01EPF9, Y1262619, Y229331, Y5013750, Y6318571, ZB1936, ZWC71125, ZXC197648, bbls00138413549
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -1.6
- Heavy atoms count
- 36
- Rotatable bond count
- 9
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.42857142857143
- Polar surface area (Å)
- 148
- Hydrogen bond acceptors count
- 7
- Hydrogen bond donors count
- 3
- Zoom the structure
- CSSB00138413549
Items Overall 82 items from 22 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BLD PHARMATECH LTD CN | 1 day | China To: | 98 | 25 mg | 198.00 | |
| BLD PHARMATECH LTD CN | 1 day | China To: | 98 | 50 mg | 301.00 | |
| BLD PHARMATECH LTD CN | 1 day | China To: | 98 | 100 mg | 385.00 | |
| BLD PHARMATECH LTD CN | 1 day | China To: | 98 | 250 mg | 712.00 | |
Description: Name:N-(4-Aminobutyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate; Hazard statement: 6.1; CAS: 1799711-25-3 | ||||||
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 98 | 100 mg | 385.00 | |
Description: Name:N-(4-Aminobutyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate; Hazard statement: 6.1; CAS: 1799711-25-3 | ||||||
| 1st Scientific LLC | 3 days | United States To: | 98 | 1 mg | 28.60 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 5 mg | 35.20 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 10 mg | 44.00 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 25 mg | 56.10 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 50 mg | 71.50 | |
Description: Thalidomide-O-Amido-C4-NH2 (TFA); CAS: 1799711-25-3 | ||||||
| AK Scientific Inc. | 5 days | United States To: | 95 | 1 mg | 53.90 | |
| AK Scientific Inc. | 5 days | United States To: | 95 | 5 mg | 66.00 | |
| AK Scientific Inc. | 5 days | United States To: | 95 | 10 mg | 82.50 | |
| AK Scientific Inc. | 5 days | United States To: | 95 | 25 mg | 105.60 | |
| AK Scientific Inc. | 5 days | United States To: | 95 | 50 mg | 136.40 | |
| AK Scientific Inc. | 5 days | United States To: | 95 | 100 mg | 232.10 | |
| AK Scientific Inc. | 5 days | United States To: | 95 | 250 mg | 440.00 | |
Description: Thalidomide-O-amido-C4-NH2 TFA; CAS: 1799711-25-3 | ||||||
| AiFChem | 5 days | United States To: | 98 | 50 mg | 287.00 | |
| AiFChem | 5 days | United States To: | 98 | 100 mg | 367.00 | |
| AiFChem | 5 days | United States To: | 98 | 250 mg | 678.00 | |
Description: N-(4-Aminobutyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate; Hazard statement: H301, H312, H361; CAS: 1799711-25-3 | ||||||
| ChemScene CN | 5 days | China To: | 98 | 100 mg | 350.00 | |
| ChemScene CN | 5 days | China To: | 98 | 500 mg | 1,350.00 | |
| ChemScene CN | 5 days | China To: | 98 | 1 g | 2,500.00 | |
| ChemScene CN | 5 days | China To: | 98 | 2 g | 3,500.00 | |
Description: Thalidomide-O-amido-C4-NH2 (TFA); CAS: 1799711-25-3 | ||||||
| AiFChem CN | 10 days | China To: | 98 | 25 mg | 189.00 | |
| AiFChem CN | 10 days | China To: | 98 | 1 g | 2,315.00 | |
Description: N-(4-Aminobutyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate; Hazard statement: H301, H312, H361; CAS: 1799711-25-3 | ||||||
| Angene International Limited | 10 days | China To: | 98 | 25 mg | 217.80 | |
| Angene International Limited | 10 days | China To: | 98 | 50 mg | 245.70 | |
| Angene International Limited | 10 days | China To: | 98 | 100 mg | 389.70 | |
| Angene International Limited | 10 days | China To: | 98 | 250 mg | 765.90 | |
| Angene International Limited | 10 days | China To: | 98 | 500 mg | 1,088.10 | |
Description: Thalidomide-O-Amido-C4-NH2 (TFA); CAS: 1799711-25-3 | ||||||
| Angel Pharmatech Ltd. | 10 days | China To: | 97 | 100 mg | 550.00 | |
| Angel Pharmatech Ltd. | 10 days | China To: | 97 | 250 mg | 950.00 | |
| Angel Pharmatech Ltd. | 10 days | China To: | 97 | 1 g | 1,950.00 | |
Description: CAS: 1799711-25-3 | ||||||
| Astatech CN | 10 days | China To: | 95 | 100 mg | 764.50 | |
| Astatech CN | 10 days | China To: | 95 | 250 mg | 1,512.50 | |
Description: THALIDOMIDE-O-AMIDO-C4-NH2 (TFA); CAS: 1799711-25-3 | ||||||
| A2B Chem | 12 days | United States To: | 95 | 5 mg | 32.20 | |
| A2B Chem | 12 days | United States To: | 95 | 10 mg | 47.15 | |
| A2B Chem | 12 days | United States To: | 95 | 25 mg | 75.90 | |
| A2B Chem | 12 days | United States To: | 95 | 50 mg | 102.35 | |
Description: Thalidomide-O-Amido-C4-NH2 (TFA); CAS: 1799711-25-3 | ||||||
| AA BLOCKS | 12 days | United States To: | 90 | 5 mg | 56.10 | |
| AA BLOCKS | 12 days | United States To: | 90 | 10 mg | 70.40 | |
| AA BLOCKS | 12 days | United States To: | 90 | 25 mg | 100.10 | |
| AA BLOCKS | 12 days | United States To: | 90 | 50 mg | 138.60 | |
| AA BLOCKS | 12 days | United States To: | 90 | 250 mg | 687.50 | |
Description: Thalidomide-O-Amido-C4-NH2 (TFA); CAS: 1799711-25-3 | ||||||
| Ambeed CN | 12 days | China To: | 98 | 25 mg | 178.20 | |
| Ambeed CN | 12 days | China To: | 98 | 50 mg | 270.90 | |
| Ambeed CN | 12 days | China To: | 98 | 100 mg | 346.50 | |
| Ambeed CN | 12 days | China To: | 98 | 250 mg | 640.80 | |
Description: Name: Thalidomide-O-amido-C4-NH2 TFA; Hazard statement: 6.1; CAS: 1799711-25-3 | ||||||
| Ambeed, Inc. | 12 days | United States To: | 98 | 25 mg | 178.20 | |
| Ambeed, Inc. | 12 days | United States To: | 98 | 50 mg | 270.90 | |
| Ambeed, Inc. | 12 days | United States To: | 98 | 100 mg | 346.50 | |
| Ambeed, Inc. | 12 days | United States To: | 98 | 250 mg | 640.80 | |
Description: Name: Thalidomide-O-amido-C4-NH2 TFA; Hazard statement: 6.1; CAS: 1799711-25-3 | ||||||
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 100 mg | 201.25 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 250 mg | 343.85 | |
| Fluorochem CN | 14 days | China To: | 98 | 100 mg | 432.00 | |
| Fluorochem CN | 14 days | China To: | 98 | 500 mg | 1,612.00 | |
| Fluorochem CN | 14 days | China To: | 98 | 1 g | 2,984.00 | |
| Fluorochem CN | 14 days | China To: | 98 | 2 g | 4,177.00 | |
Description: Thalidomide-O-amido-C4-NH2 (TFA); ; Storage Conditions: ambient storage; Hazard Codes: H302, H315, H319, H335; GHS Pictograms: GHS07; CAS: 1799711-25-3 | ||||||
| BB4LS GS | 15 days | Germany To: | 98 | 50 umol | 283.50 | |
| BB4LS GS | 15 days | Germany To: | 98 | 100 umol | 288.75 | |
| BB4LS GS | 15 days | Germany To: | 98 | 200 umol | 294.00 | |
| BB4LS GS | 15 days | Germany To: | 98 | 300 umol | 1,154.25 | |
| BB4LS GS | 15 days | Germany To: | 98 | 500 umol | 1,174.50 | |
| eNovation CN | 20 days | China To: | 98 | 25 mg | 161.00 | |
| eNovation CN | 20 days | China To: | 98 | 50 mg | 224.25 | |
| eNovation CN | 20 days | China To: | 98 | 100 mg | 339.25 | |
| eNovation CN | 20 days | China To: | 98 | 250 mg | 506.00 | |
| eNovation CN | 20 days | China To: | 98 | 1 g | 1,788.25 | |
Description: N-(4-Aminobutyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate; CAS: 1799711-25-3 | ||||||
| Accel Scientific, S.L. | 20 days | China To: | 98 | 25 mg | 221.10 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 50 mg | 330.00 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 100 mg | 522.50 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 250 mg | 776.60 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 500 mg | 1,459.70 | |
Description: Thalidomide-O-amido-C4-NH2 (TFA); CAS: 1799711-25-3 | ||||||
| Advanced ChemBlock Inc | 20 days | United States To: | 95 | 100 mg | 345.00 | |
| Advanced ChemBlock Inc | 20 days | United States To: | 95 | 250 mg | 690.00 | |
Description: Thalidomide-O-amido-C4-NH2 TFA; CAS: 1799711-25-3 | ||||||
| Advanced ChemBlocks CN | 20 days | China To: | 95 | 100 mg | 345.00 | |
| Advanced ChemBlocks CN | 20 days | China To: | 95 | 250 mg | 690.00 | |
Description: Thalidomide-O-amido-C4-NH2 TFA; CAS: 1799711-25-3 | ||||||
| 10X CHEM | TBD | United States To: | 90 | 5 mg | 25.30 | |
| 10X CHEM | TBD | United States To: | 90 | 10 mg | 37.40 | |
| 10X CHEM | TBD | United States To: | 90 | 25 mg | 56.10 | |
| 10X CHEM | TBD | United States To: | 90 | 50 mg | 72.60 | |
Description: Thalidomide-O-Amido-C4-NH2 (TFA); CAS: 1799711-25-3 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of N-(6-aminohexyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid - CSSB00159265600](/st/structure/200/0779da0f4940b74d087c370bc5c56669/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCCCCCNC%2528%253DO%2529COC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
![Chemical structure of N-(8-aminooctyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid - CSSB00138413550](/st/structure/200/4dcef927bc48275aabee172de1aeb952/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCCCCCCCNC%2528%253DO%2529COC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
![Chemical structure of N-(5-aminopentyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid - CSSB06256034978](/st/structure/200/35390d0689be73738f81aae170907b64/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCCCCNC%2528%253DO%2529COc1cccc2C%2528%253DO%2529N%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529c12.png)
![Chemical structure of N-(3-aminopropyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid - CSSB00161188928](/st/structure/200/629817e50df8aa162fa0ab07e1551908/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCCNC%2528%253DO%2529COC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
![Chemical structure of N-(3-{2-[2-(3-aminopropoxy)ethoxy]ethoxy}propyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid - CSSB03437847026](/st/structure/200/65a46124d0fa428123cada7cea69155c/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCCOCCOCCOCCCNC%2528%253DO%2529COC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
![Chemical structure of N-{2-[2-(2-aminoethoxy)ethoxy]ethyl}-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid - CSSB00159269543](/st/structure/200/72724215a119a26c027e576698c19de1/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCOCCOCCNC%2528%253DO%2529COC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
![Chemical structure of N-(2-{2-[2-(2-aminoethoxy)ethoxy]ethoxy}ethyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid - CSSB00161188577](/st/structure/200/d448481d1b3776eb54f1a5a6e2608601/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCOCCOCCOCCNC%2528%253DO%2529COC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
